Foundation Medicine, Novartis partner up on companion diagnostics in oncology

A company focused on next-generation sequencing-based diagnostics is partnering with a large Swiss drugmaker. Foundation Medicine, based in Cambridge, Massachusetts, said Wednesday that it had formed a collaboration with Novartis. The development and commercialization partnership will involve Novartis using the diagnostics maker’s comprehensive genomic profiling assay, FoundationOne CDx, to […]

Leave a Reply